5-羟色胺转运体基因多态性与SSRIs疗效
被引量:4
摘要
本文就 5 -羟色胺转运体多态性与 SSRIs疗效之间关系作一综述。
出处
《国外医学(精神病学分册)》
2005年第1期55-58,共4页
Foreign Medical Sciences(Section of Psychiatry)
参考文献14
-
1Nakamura M, Ueno S, Sano A, et,al. The human serotonin transporter gene linked ploymorphism (5-HTTLPR)shows ten novel allelic variants. Mol Psychiatry; 2000; 5(1): 32-38.
-
2Lesch KP. Serotonin transporl;er and psychiatric disorders: listening to the gene. Neuroscientist, 1998; 4(1): 25-34.
-
3Smeraldi E, Zanardi R, Benedettl F, et al. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry, 1998; 3 (6): 508-511.
-
4Yu YW, Tsai SJ, Chen TJ, et al. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorder.s. Mol Psychiatry, 2002; 7 (10) : 1115-1119.
-
5Kim DK, Lim S-W, Sohn SE, et al. Serotonin transporter gene polymorphism and antidepressant response. Neurbreport, 2000; 11 (1): 215-219.
-
6Rausch JL, John ME, Fei YJ, et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry, 2002 May1; 51 (9): 723-732.
-
7Whale R, Quested DJ, Layer D, et al. Serotonin transporter (5-HTT) Promoter genotype ,may influence the prolactin response to clomipramine. Psychopharmacology (Berl), 2000May; 150 (1): 120-122.
-
8Weizman A, Weizman R. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse. Pharmacogenomics, 2000 Aug; 1 (3): 335-341.
-
9McDougle CJ, Epperson CN, Price LH, et al. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry, 1998; 3 (3): 270-273.
-
10Billet EA, Richter MA, King N, et al. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry,1997; 2 (5): 403-406.
同被引文献104
-
1兑立栋,谭庆荣,张凤刚,张瑞国,郭立,张雅红.抑郁症易感性与5-羟色胺转运体基因的多态性[J].中国临床康复,2005,9(20):140-141. 被引量:5
-
2李春波,邹政,方芳,汪栋祥,吴文源.五羟色胺转运体启动子区多态性与焦虑症的关联研究[J].中国行为医学科学,2006,15(1):34-35. 被引量:12
-
3杨焱.烟草的危害、流行特点及控制策略[J].中国健康教育,2006,22(5):387-389. 被引量:94
-
4Baillie AJ ,Mattick RP, Hall W. Quitting smoking:estimatlon by recta-analysis of the rate of unaided smoking cessation. Aust J Public Health, 1995,19 : 129-131.
-
5Moxham J. Nicotine addiction. BMJ, 2000,320 : 391-392.
-
6True WR. Heath AC, Scherrer JF, et al. Genetic and environmental contributions to smoking. Addiction, 1997, 92: 1277-1287.
-
7Heath AC. Martin NG. Genetic models for the natural history of smoking; evidence for a genetic influence on smoking persistence. Addict Behav. 2003,18 ; 1,9-34.
-
8Vink JM. Willemsen G. Boomsma DI. Heritability of smoking initiation and nicotine dependence. Behav Genet. 2006,35:397- 406.
-
9Lessov CN, Swan GE, Ring HZ. Genetics and drug use as a complex phenotype. Subst Use Misuse,2004,39 : 1515-1569.
-
10Rossi S.Singer S, Shearman E, et al. The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes. Neurochem Res, 2005,30 : 541-548.
引证文献4
-
1乔艳辉,多力坤.买买提玉素甫.5-羟色胺转运体基因多态性与焦虑相关人格特质[J].国际遗传学杂志,2006,29(4):295-298. 被引量:1
-
2乔艳辉,马合木提.哈力克,左宏莉,吐尔洪.克维尔,多力坤.买买提玉素甫.新疆维、哈、蒙古族5-HTT基因启动子区多态性的研究[J].人类学学报,2007,26(3):259-263. 被引量:1
-
3褚水莲,肖丹,王辰.吸烟成瘾的分子遗传机制研究进展[J].国际呼吸杂志,2008,28(16):988-993. 被引量:1
-
4褚水莲,肖丹.吸烟与5-羟色胺系统相互关系的研究进展[J].中华内科杂志,2008,47(11):957-958. 被引量:1
二级引证文献4
-
1多力坤.买买提玉素甫,阿地拉.多力坤,伊力哈木.乃扎木,吐尔逊.买买提,布左拉.司马义.和田维吾尔族老人5-HTTLPR基因插入/缺失多态性研究及长寿的关联分析[J].科技导报,2012,30(26):57-61.
-
2刘卫红,邱延超,李克宁,张香馥,陈凤格.石家庄市居民健康知识和健康行为调查分析[J].医学动物防制,2014,30(1):68-71.
-
3刘勇,王朝忠.全身麻醉下吸烟病人体温与体温调节性血管收缩阈值的变化[J].安徽医药,2016,20(3):563-567. 被引量:2
-
4闵文蛟,周波,马敏,李云歌,刘传新,张波,孙学礼.5-羟色胺转运蛋白基因多态性与抑郁症临床表型的关联性[J].中华行为医学与脑科学杂志,2016,25(9):797-802. 被引量:9
-
1陈国统,王伟松,袁宗琪,蒋宇晓.新型抗抑郁药合并奎硫平治疗难治性抑郁症的疗效研究[J].中国农村卫生事业管理,2012,32(6):655-656. 被引量:1
-
2丘脑下核刺激可治疗严重的强迫症[J].中华医学信息导报,2008,23(24):6-6.
-
3张蓉.5-羟色胺重摄取抑制剂类药物与心理疏导联合治疗卒中后抑郁症临床观察[J].临床医药实践,2007,16(10):995-996. 被引量:1
-
4邹卿,潘小平.5-HTT基因多态性与情感障碍发病及SSRIs疗效的相关性分析[J].中国现代医生,2008,46(21):68-70.
-
5丁关庆.抑郁症问答[J].中老年保健,2013(6):16-17.
-
6邱书萍.氟西汀的药理作用及应用现状[J].临床和实验医学杂志,2007,6(10):131-131. 被引量:3
-
7宁洁,李伟民,卢殿军.强迫症短程心理治疗前药物铺垫与治疗效果的关系[J].重庆医学,2004,33(7):1089-1090. 被引量:3
-
8张延霞,张桂青,阮宁,胡敏,赵倩.难治性抑郁症治疗前后血浆单胺类神经递质代谢产物的变化[J].现代生物医学进展,2011,11(7):1352-1354. 被引量:6
-
9黄世杰.葛兰素史克公司不同意帕罗西汀的成年人自杀性研究结果[J].国外医学(药学分册),2006,33(1):62-62. 被引量:2
-
10Thormahlen GM.,王小艳.妊娠期间使用帕罗西汀安全吗?[J].中国处方药,2006,5(10):25-25.